Incredo has raised $30 million in Series C funding to advance its innovative sugar reduction technology, aiming to reduce sugar content in food by 30% to 50% without compromising taste.

Target Company Overview

Incredo is a pioneering company focused on revolutionary sugar alternatives, specifically designed to bind real cane or beet sugar with a natural carrier. This innovative technology allows for a reduction of sugar in food products by 30% to 50%, maintaining the same taste, texture, and mouthfeel without altering the original ingredients. This capability offers significant benefits for consumers looking to minimize sugar intake while enjoying their favorite foods.

Since Ari Melamud took over as CEO in 2021, Incredo has successfully transitioned its flagship product, Incredo Sugar, to commercial availability. This progress includes a recent Series C funding round, where Incredo raised $30 million, bringing its total fundraising efforts since its Series B round in 2019 to $60 million.

Industry Overview

The sugar replacement industry has faced both challenges and opportunities, particularly as consumer awareness rises regarding sugar consumption and health risks associated with sugary diets. The World Health Organi

View Source

Similar Deals

Bradford Solo Laboratories, Inc.

2025

Other Personal Products (NEC) United States of America
Eshbal Functional Food Inc. Dare to be Different Foods, Inc.

2025

Other Special Foods & Wellbeing Products United States of America
Constellation Brands, Inc. The Wine Group

2025

Other Distillers & Wineries (NEC) United States of America
Celsius Alani Nu

2025

Other Energy Drinks United States of America
Essity Edgewell Personal Care’s feminine care business

2025

Other Sanitary Products United States of America
Mammoth Brands Coterie

2025

Other Sanitary Products United States of America

DSM-Firmenich Venturing and Sienna Venture Capital

invested in

Incredo

in 2023

in a Other deal

Disclosed details

Transaction Size: $30M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert